Recruiting
De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You
This is a live biobank study for breast cancer (BC) patients where samples will be collected at inflection points in the course of the disease.
ClinicalTrials.gov IDNCT05134779
PhaseNot Applicable
Enrollment400
SponsorWeill Medical College of Cornell University
Age18 Years
SexFEMALE
Conditions studied
Breast Cancer
About this study
This is a live biobank study for breast cancer (BC) patients where samples will be collected at inflection points in the course of the disease.
Interventions
- Procedure: Live Biobank — Tumor tissue will be collected from consented patients at sequential inflection points in the disease course: at the time of initial diagnosis, at the time of surgery and during recurrence or metastasis. In addition to this, 40ml of research bloods will also be collected at these key inflection points.
Primary outcomes
- establish a live biobank for breast cancer patients (60 months)
Eligibility information
Inclusion Criteria:
* All patients will historically proven BC are eligible to be on the study
Exclusion Criteria:
* Carriers of other cancers other than breast.
Study locations
- Brooklyn Methodist Hospital - NewYork Presbyterian, New York, New York 11215 United States
- New York Presbyterian Hospital - Queens, New York, New York 11355 United States
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.